PHARM.ASSY
0689.606.850 · rovalta.com · 10/11/2026
ACTIVE
PHARM.ASSY
Financial year 2025 · Closed on 31/12/2025
Net result25,2 k €-3,1 %over 1 year
Gross margin101,1 k €+5,1 %over 1 year
Equity149,6 k €+19,8 %over 1 year
Overview
Identity
Source · BCE/KBOPHARM.ASSY is a Private company with limited liability incorporated in 2018. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Wemmel.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0689.606.850
- Incorporation
- 31/01/2018
- Legal form
- Private company with limited liability
- Registered office
- Chée de Merchtem 33
1780 Wemmel · FlandreSee on map - Contributed capital
- 18 550,00 €
- Latest accounts
- 31/12/2025
Activities (NACE)
Joint committees (1)
- 3130
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts
Financials
Source · NBB, 8 filingsTrend over 7 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 101,1 k € | +5.1% | 96,1 k € | -10.7% | 107,7 k € | +10.8% | 97,2 k € | +7.2% | 90,7 k € |
| EBITDA | 67,9 k € | +5.4% | 64,4 k € | -15.3% | 76,1 k € | +15.5% | 65,9 k € | +4.0% | 63,3 k € |
| Operating result | 39,7 k € | +4.3% | 38,1 k € | +5.9% | 36 k € | +34.0% | 26,9 k € | -10.7% | 30,1 k € |
| Net result | 25,2 k € | -3.1% | 26 k € | -3.9% | 27 k € | +65.9% | 16,3 k € | -30.2% | 23,4 k € |
| Balance sheet | |||||||||
| Equity | 149,6 k € | +19.8% | 125 k € | +26.3% | 99 k € | +37.6% | 71,9 k € | +29.3% | 55,6 k € |
| Total assets | 269 k € | +11.1% | 242,1 k € | -1.9% | 246,8 k € | -7.2% | 265,8 k € | +2.0% | 260,5 k € |
| Cash | 47,4 k € | +4.6% | 45,3 k € | +42.1% | 31,9 k € | +17.7% | 27,1 k € | +7.7% | 25,1 k € |
| Debts | 119,3 k € | +1.9% | 117,1 k € | -20.7% | 147,7 k € | -23.8% | 193,9 k € | -5.4% | 204,9 k € |
| Other | |||||||||
| Workforce | – | 1,0 ETP | 0.0% | 1,0 ETP | 0.0% | 1,0 ETP | 0.0% | 1,0 ETP | |
Valuation
Indicative valuation
As an indication, this company is worth
between 250 k€ and 500 k€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20251 active · 1 ended
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Yara Nelly Nada Assy | Directorsince 31/01/2018 |
Ended mandates
| Director | Mandates in this company | Period |
|---|---|---|
Yara ASSY | Mandate2024 accounts |
Other companies at this address
Chée de Merchtem 33 1780 Wemmel| Company | CBE no. |
|---|---|
CARNIER ARCHITECTUUR● Active | 0739.546.212 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 31/08/2026 | 14/07/2025 | 08/07/2024 | 21/08/2023 | 29/08/2022 | 26/08/2021 |
| General meeting | 28/08/2026 | 26/05/2025 | 27/05/2024 | 30/05/2023 | 30/05/2022 | 31/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 8 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 28/08/2026 | 31/08/2026 | Dutch | |
| Abridged model | 31/12/2024 | 26/05/2025 | 14/07/2025 | French | |
| Abridged model | 31/12/2023 | 27/05/2024 | 08/07/2024 | French | |
| Abridged model | 31/12/2022 | 30/05/2023 | 21/08/2023 | French | |
| Abridged model | 31/12/2021 | 30/05/2022 | 29/08/2022 | French | |
| Abridged model | 31/12/2020 | 31/05/2021 | 26/08/2021 | French | |
| Abridged modelCorrection | 31/12/2019 | 25/05/2020 | 12/11/2020 | French | |
| Abridged model | 31/12/2019 | 25/05/2020 | 31/08/2020 | French |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 250 k€ and 500 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 1 ended
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Yara Nelly Nada Assy | Directorsince 31/01/2018 |
Ended mandates
| Director | Mandates in this company | Period |
|---|---|---|
Yara ASSY | Mandate2024 accounts |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other02/02/2018OPRICHTING - BENOEMINGEN
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsYear
Identity
Incorporation
Name
Registered office
Annual accounts
Filings7 filings
Mandates
Yara Nelly Nada Assy
Yara ASSY
201820192020202120222023202420252026
PHARM.ASSY
Chée de Merchtem 33, 1780 Wemmel
Director
CurrentPlanned, not yet servedEndedAccounts filedToday
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Chée de Merchtem 33, 1780 WemmelCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00483204 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| PHARM.ASSYCurrent | accounts 2019 → 2025 | Accounts 2025 · 2026-00483204 |
Events
- 2025Annual accounts 202525,2 k €↓
- 2024Annual accounts 202426 k €↓
- 2023Annual accounts 202327 k €↑
- 2022Annual accounts 202216,3 k €↓
- 2021Annual accounts 202123,4 k €↑
- 2020Annual accounts 202013 k €↑
- 2019Annual accounts 2019679,7 €
- 31/01/2018IncorporationPrivate company with limited liability